Human Monoclonal Antibodies against Pseudomonas aeruginosa Lipopolysaccharide Derived from Transgenic Mice Containing Megabase Human Immunoglobulin Loci Are Opsonic and Protective against Fatal Pseudomonas Sepsis

Pseudomonas aeruginosa is a significant human pathogen, and no vaccine is commercially available. Passive antibody prophylaxis using monoclonal antibodies (MAb) against protective P. aeruginosa epitopes is an alternative strategy for preventing P. aeruginosa infection, but mouse MAb are not suitable...

Full description

Bibliographic Details

Published in:	Infect Immun
Main Authors:	Hemachandra, Sonali, Kamboj, Kulwant, Copfer, Janna, Pier, Gerald, Green, Larry L., Schreiber, John R.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 2001
Subjects:	Microbial Immunity and Vaccines
Online Access:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC98149/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11254577/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/IAI.69.4.2223-2229.2001
Tags:	Add Tag No Tags, Be the first to tag this record!